Loading patent…
AssigneeHinova Pharmaceuticals Inc.
InventorsJing LI, Wu DU, Guoqing LIU, Yongxu HUO, Kefan CHEN, Xinghai LI
Estimating the term…
Provided is a drug for treating triple negative breast cancer. Provided is use of an androgen receptor (AR) degrader (including PROTAC) in the preparation of a drug for preventing and/or treating triple negative breast cancer (including androgen receptor positive triple negative breast cancer). Provided is use of an AR degrader in combination with a targeting drug (comprising a PI3Kα inhibitor and a PARP inhibitor), an immunotherapy drug or a chemotherapeutic drug in the preparation of a drug for preventing and/or treating triple negative breast cancer.
An AR degrader (including proteolysis targeting chimera (PROTAC)) for use in the manufacture of medicaments for the prevention and/or treatment of triple negative breast cancer.
Dependencies are inferred from the claim text.